Thrombospondin 1 and 2 regulate mesenchymal progenitor cell fate and matrix organization
Madysen K. Hunter , Sneha Korlakunta , Neda Vishlaghi , Monisha Mittal , Kyle Cragg , Conan Juan , Chase A. Pagani , Yuxiao Sun , Lindsey Lammlin , Karen Kessell , Dylan Feist , Ji Hae Choi , Meng-Lun Hsieh , Jahnu Saikia , Craig L. Duvall , Heeseog Kang , Andrea I. Alford , Kurt D. Hankenson , Robert J. Tower , Tristan Maerz , Benjamin Levi
Bone Research ›› 2026, Vol. 14 ›› Issue (1) : 10
Thrombospondin 1 and 2 regulate mesenchymal progenitor cell fate and matrix organization
Thrombospondin 1 and 2 (TSP1 and TSP2) are critical regulators of extracellular matrix (ECM) interactions, influencing cell differentiation and tissue repair. Recent discoveries from our laboratory and others highlight the importance of altered ECM alignment in influencing aberrant mesenchymal progenitor cell (MPC) differentiation and subsequent ectopic bone formation in trauma-induced heterotopic ossification (HO). However, the key regulators of this MPC to ECM interaction have yet to be elucidated. This study uncovers the role of matricellular TSP1 and TSP2 in MPC/ECM interaction as well as HO formation and progression. Using single-cell RNA sequencing, spatial transcriptomics, and in vivo models, we found that TSP1 is upregulated in tissue remodeling macrophages and MPCs at the injury site, while TSP2 is restricted to MPCs surrounding the HO anlagen. TSP1/2 double knockout (DKO) mice exhibited significantly reduced HO volume and disrupted ECM alignment. These findings highlight the crucial roles of TSP1 and TSP2 in musculoskeletal injury repair as well as HO formation and progression, supporting the potential to therapeutically target TSP1 and TSP2 to prevent HO.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
Junko, M., Ayumu, Y., Erquan, Z., Hirofumi, S. & Kazuo, M. In Pulmonary Hypertension (eds Elwing Jean, M. & Panos Ralph, J.) Ch. 4 (IntechOpen, 2013). |
| [20] |
|
| [21] |
Hankenson, K. D. et al. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J. Bone Miner. Res.15, 851–862 (2000). |
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
Crossley, J. L. et al. Itaconate-producing neutrophils regulate local and systemic inflammation following trauma. JCI Insight8, e169208 (2023). |
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
Patel, N. K. et al. Macrophage TGF-β signaling is critical for wound healing with heterotopic ossification after trauma. JCI Insight7, e144925 (2022). |
| [31] |
|
| [32] |
|
| [33] |
Torossian, F. et al. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications. JCI Insight2, e96034 (2017). |
| [34] |
Li, C. et al. Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases. JCI Insight5, e126453 (2019). |
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
Chu, T. L. et al. MMP14 cleaves PTH1R in the chondrocyte-derived osteoblast lineage, curbing signaling intensity for proper bone anabolism. Elife12, e82142 (2023). |
| [48] |
|
| [49] |
Zhang, K., Li, M., Yin, L., Fu, G. & Liu, Z. Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review). Int. J. Mol. Med.45, 1275–1293 (2020). |
| [50] |
Röszer, T. In The M2 Macrophage (ed. Röszer, T.) 133–151 (Springer International Publishing, 2020). |
| [51] |
Olmsted-Davis, E., Mejia, J., Salisbury, E., Gugala, Z. & Davis, A. R. A population of M2 macrophages associated with bone formation. Front. Immunol.12, 686769 (2021). |
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
The Author(s)
/
| 〈 |
|
〉 |